Upcoming ASH Meetings
ASH offers premier educational and scientific meetings and workshops for hematology professionals worldwide. Browse the ASH events below to find your next hematology meeting.
ASH Annual Meeting & Exposition
December 5-8, 2020
San Diego, CA
Attend the world’s most comprehensive hematology event of the year for an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology.
Highlights of ASH®
Nine locations, one great program
Learn how new clinical research presented at the latest ASH annual meeting will influence hematology patient care. Attend one of nine meetings worldwide.
ASH Meeting on Lymphoma Biology
August 6-9, 2020
Further your understanding of lymphoma pathogenesis and therapy through scientific exchange based on basic and translational research in lymphoma and lymphoma malignancies.
ASH Meeting on Hematologic Malignancies
September 11-12, 2020
"How I Treat" presentations are the focus of this meeting, which features the top experts in hematologic malignancies in an intimate setting with no competing sessions.
ASH Consultative Hematology Course
September 10, 2020
December 7, 2020
Update your core knowledge of non-malignant hematology by attending this interactive, half-day course intended for clinical hematologists based in community practice in North America.
ASH Summit on Immunotherapies for Hematologic Diseases
April 1-2, 2021
Omni Shoreham, Washington, DC
Gain insights into the critical limitations of immunotherapies, explore ways in which these therapies can be improved for widespread use in patients with hematologic malignancies and learn about the application of immunotherapies for the treatment of non-malignant hematologic diseases.
ASH Summit on Emerging Immunotherapies for Hematologic Diseases
Held in July 2018, this small-group meeting examined preclinical and clinical factors influencing the effective development, regulation, and implementation of immunotherapies for hematologic diseases.
FDA-ASH Sickle Cell Disease Clinical Endpoints Workshop
Held in October 2018, this workshop identified opportunities to bring uniformity and standards to existing sickle cell disease endpoints, discussed current gaps, and proposed development of new endpoints as a focus for future research.
This free education program aims to provide guidance to the interdisciplinary MDS and AML care team on optimal diagnosis and classification, treatment selection, patient education, and more.